Arthur David Conigrave

Brief description

Professor Arthur Conigrave was appointed Dean of Sydney Medical School in 2016. As Dean, he leads one of the largest medical schools in Australia and the most research-intensive faculty within the University of Sydney. Sydney Medical School has more than 3000 academic faculty members and teaches over 5000 students across undergraduate medical sciences, medicine, postgraduate professional courses and higher research degrees. Prior to his appointment as Dean, Professor Conigrave held a number of leadership roles including Head of the School of Molecular Bioscience from 2007-10 and since 2011, Deputy Dean and Associate Dean (Finance and Administration) in Sydney Medical School.

Professor Conigrave is an endocrinologist specialising in the clinical management of patients with metabolic bone disease (including osteoporosis and disorders of calcium metabolism), and an internationally recognised researcher in molecular endocrinology. He has a special interest in the manner in which cells ‘sense’ nutrients in their external environment and the role of nutrient-sensing receptors in the metabolic basis of health and disease. Professor Conigrave’s work has clarified the links between calcium and amino acid metabolism, which has implications for bone health and disease. He is an expert on Calcium Sensing Receptor (CaSR) signaling mechanisms and he accurately predicted that the CaSR mediates L-amino acid-induced release of important gut hormones. Professor Conigrave is past Chair of the NHMRC Grant Review Panel in Musculoskeletal Medicine and a two-time winner of the Lilly Endocrinology Research Awards.

Full description